<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="activity\PMC8036487\results\search\plant_compound\results.xml">
  <result pre="scientific literature. coronavirus infections pandemics natural compounds clove Syzygium aromaticum" exact="eugenol" post="eugeniin SARS-CoV-2 COVID-19 phytochemicals herbal medicine 1. Introduction Coronaviridae"/>
  <result pre="Administration (FDA) agency has confirmed the safety of clove buds," exact="clove oil," post="and some clove ingredients as a food supplement [63],"/>
  <result pre="and Î³- and Î´-cadinene [79]. Crategolic acid, vanillin, gallotannic acid," exact="methyl salicylate," post="eugeniin, rhamnetin, kaempferol, eugenitin, oleanolic acid, methyl amyl ketone,"/>
  <result pre="salicylate, eugeniin, rhamnetin, kaempferol, eugenitin, oleanolic acid, methyl amyl ketone," exact="methyl salicylate," post="Î±- and Î²-humulene, benzaldehyde, chavicol, and Î²-ylangene are present"/>
  <result pre="and Î²-ylangene are present in lesser amounts [74]. In particular," exact="eugenol" post="and minor constituents like methyl salicylate and methyl amyl"/>
  <result pre="lesser amounts [74]. In particular, eugenol and minor constituents like" exact="methyl salicylate" post="and methyl amyl ketone are responsible for the characteristic"/>
  <result pre="mL/kg [83]. Interestingly, at this dosage, the anti-inflammatory effect of" exact="clove oil" post="matches that of anti-inflammatory drugs like etodolac and indomethacin"/>
  <result pre="contribute to clove anti-inflammatory properties [85,86,87,88,89]. In experimental animal models," exact="eugenol" post="(at 200 and 400 mg/kg doses) was shown to"/>
  <result pre="by the treatment with both whole clove aqueous extract and" exact="eugenol" post="through a reduction of TNF-Î± (tumor necrosis factor alpha)"/>
  <result pre="improving disease resistance [54]. In experimental studies on animal models," exact="clove oil" post="improved the total white blood cell count and enhanced"/>
  <result pre="used as a tonic for the cardiovascular system [82]. Moreover," exact="clove oil" post="was shown to inhibit the platelet aggregation induced by"/>
  <result pre="[74]. In vivo experiments carried out on rabbits showed that" exact="clove oil" post="at 50â€&quot;100 mg/kg doses afforded total protection against the"/>
  <result pre="the molecular basis for the clove antithrombotic effects, the main" exact="clove oil" post="constituent, eugenol, has shown activity as a platelet inhibitor,"/>
  <result pre="research groups. The above-mentioned Tragoolpua and Jatisatienr [101] used pure" exact="eugenol" post="as the reference compound in their anti-HSV studies and"/>
  <result pre="were obtained by Benencia and Courreges [103], who reported the" exact="eugenol" post="inhibition of HSV-1 and HSV-2 replication with inhibitory concentration"/>
  <result pre="25.6 Âµg/mL and 16.2 Âµg/mL, respectively. In the same study," exact="eugenol" post="was virucidal, whilst no compound-associated cytotoxicity was revealed at"/>
  <result pre="Syzygium aromaticum L. extractsAsian J. Biol. Sci.2011428229010.3923/ajbs.2011.282.290 60.OgataM.HoshiM.UranoS.EndoT.Antioxidant activity of" exact="eugenol" post="and related monomeric and dimeric compoundsChem. Pharm. Bull.2000481467146910.1248/cpb.48.146711045452 61.DarshanS.DoreswamyR.Patented"/>
  <result pre="the effects of temperature and pressure on the extraction of" exact="eugenol" post="from clove (Syzygium aromaticum) leaves using supercritical CO2J. Supercrit."/>
  <result pre="of secretory phospholipase A2Molecules201722144110.3390/molecules22091441 90.DanielA.N.SartorettoS.M.SchmidtG.Caparroz-AssefS.M.Bersani-AmadoC.A.CumanR.K.N.Anti-inflammatory and antinociceptive activities A of" exact="eugenol" post="essential oil in experimental animal modelsRev. Bras. Farm.20091921221710.1590/S0102-695X2009000200006 91.MagalhÃ£esC.B.RivaD.R.DePaulaL.J.Brando-LimaA.KoatzV.L.G.Leal-CardosoJ.H.ZinW.A.FaffeD.S.In"/>
  <result pre="experimental animal modelsRev. Bras. Farm.20091921221710.1590/S0102-695X2009000200006 91.MagalhÃ£esC.B.RivaD.R.DePaulaL.J.Brando-LimaA.KoatzV.L.G.Leal-CardosoJ.H.ZinW.A.FaffeD.S.In vivo anti-inflammatory action of" exact="eugenol" post="on lipopolysaccharide-induced lung injuryJ. Appl. Physiol.201010884585110.1152/japplphysiol.00560.200920075264 92.ChniguirA.ZioudF.MarzaioliV.El-BennaJ.BachoualR.Syzygium aromaticum aqueous"/>
  <result pre="(HCV) proteasePhytother. Res.20001451051610.1002/1099-1573(200011)14:7&amp;lt;510::AID-PTR646&amp;gt;3.0.CO;2-B11054840 103.BenenciaF.CourregesM.In vitro and in vivo activity of" exact="eugenol" post="on human herpesvirusPhytother. Res.20001449550010.1002/1099-1573(200011)14:7&amp;lt;495::AID-PTR650&amp;gt;3.0.CO;2-811054837 104.DaiJ.-P.ZhaoX.-F.ZengJ.WanQ.-Y.YangJ.-C.LiW.-Z.ChenX.-X.WangG.-F.LiK.-S.Drug screening for autophagy inhibitors"/>
  <result pre="dissociation of Beclin1-Bcl2 complex using BiFC technique and mechanism of" exact="eugenol" post="on anti-influenza A virus activityPLoS ONE20138e6102610.1371/journal.pone.006102623613775 105.LaneT.AnantpadmaM.FreundlichJ.S.DaveyR.A.MadridP.B.EkinsS.The natural product"/>
  <result pre="eugenol on anti-influenza A virus activityPLoS ONE20138e6102610.1371/journal.pone.006102623613775 105.LaneT.AnantpadmaM.FreundlichJ.S.DaveyR.A.MadridP.B.EkinsS.The natural product" exact="eugenol" post="is an inhibitor of the ebola virus in vitroPharm."/>
 </snippets>
</snippetsTree>
